SubHero Banner
Text

Herzuma® (trastuzumab-pkrb) – New biosimilar approval

December 14, 2018 - Teva and Celltrion announced the FDA approval of Herzuma (trastuzumab-pkrb), a biosimilar to Genentech’s Herceptin® (trastuzumab).

Download PDF